T. Rowe Price Associates
MDC

T. Rowe Price Associates’s M.D.C. Holdings, Inc. MDC Stock Holding History

T. Rowe Price Associates’s Portfolio MDC Stock Details MDC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-51,013
Closed -$3.21M – 3081
2024
Q1 		$3.21M Buy
51,013
+2,210
+5% +$135K ﹤0.01% 1362
2023
Q4 		$2.7M Buy
48,803
+1,799
+4% +$79.6K ﹤0.01% 1411
2023
Q3 		$1.94M Buy
47,004
+3,212
+7% +$150K ﹤0.01% 1476
2023
Q2 		$2.05M Buy
43,792
+3,352
+8% +$140K ﹤0.01% 1466
2023
Q1 		$1.57M Buy
40,440
+1,148
+3% +$42.4K ﹤0.01% 1558
2022
Q4 		$1.24M Buy
39,292
+3,272
+9% +$101K ﹤0.01% 1662
2022
Q3 		$988K Sell
36,020
-4,679
-11% -$155K ﹤0.01% 1758
2022
Q2 		$1.31M Buy
40,699
+1,113
+3% +$39.8K ﹤0.01% 1766
2022
Q1 		$1.5M Buy
39,586
+543
+1% +$24.8K ﹤0.01% 1812
2021
Q4 		$2.18M Buy
39,043
+4,834
+14% +$246K ﹤0.01% 1681
2021
Q3 		$1.6M Buy
34,209
+1,691
+5% +$85.7K ﹤0.01% 1828
2021
Q2 		$1.65M Sell
32,518
-1,131
-3% -$64.8K ﹤0.01% 1824
2021
Q1 		$2M Buy
33,649
+1,841
+6% +$96.5K ﹤0.01% 1723
2020
Q4 		$1.43M Sell
31,808
-156
-0.5% -$6.95K ﹤0.01% 1769
2020
Q3 		$1.39M Sell
31,964
-3,429
-10% -$137K ﹤0.01% 1664
2020
Q2 		$1.17M Buy
35,393
+8,176
+30% +$226K ﹤0.01% 1716
2020
Q1 		$585K Sell
27,217
-5,779
-18% -$202K ﹤0.01% 1908
2019
Q4 		$1.17M Buy
32,996
+2,027
+7% +$76.3K ﹤0.01% 1825
2019
Q3 		$1.24M Buy
30,969
+237
+0.8% +$8.32K ﹤0.01% 1724
2019
Q2 		$933K Buy
30,732
+160
+0.5% +$4.71K ﹤0.01% 1873
2019
Q1 		$823K Buy
30,572
+1,998
+7% +$52.9K ﹤0.01% 1917
2018
Q4 		$689K Buy
28,574
+6,633
+30% +$160K ﹤0.01% 1959
2018
Q3 		$556K Buy
21,941
+317
+1% +$8.5K ﹤0.01% 2115
2018
Q2 		$570K Buy
21,624
+58
+0.3% +$1.51K ﹤0.01% 2078
2018
Q1 		$516K Buy
21,566
+2,201
+11% +$58.2K ﹤0.01% 2072
2017
Q4 		$529K Sell
19,365
-14
-0.1% -$386 ﹤0.01% 2071
2017
Q3 		$511K Hold
19,379
– – ﹤0.01% 2090
2017
Q2 		$544K Buy
19,379
+3
+0% +$79 ﹤0.01% 2034
2017
Q1 		$462K Buy
19,376
+13
+0.1% +$293 ﹤0.01% 2096
2016
Q4 		$394K Sell
19,363
-821
-4% -$15.3K ﹤0.01% 2152
2016
Q3 		$375K Sell
20,184
-4,632
-19% -$86.1K ﹤0.01% 2127
2016
Q2 		$435K Buy
24,816
+5,853
+31% +$101K ﹤0.01% 2018
2016
Q1 		$342K Buy
18,963
+1,396
+8% +$22.5K ﹤0.01% 2110
2015
Q4 		$323K Sell
17,567
-6,945
-28% -$132K ﹤0.01% 2127
2015
Q3 		$462K Buy
24,512
+3,861
+19% +$80.8K ﹤0.01% 1988
2015
Q2 		$446K Buy
20,651
+710
+4% +$14.5K ﹤0.01% 2043
2015
Q1 		$409K Buy
19,941
+295
+2% +$5.65K ﹤0.01% 2059
2014
Q4 		$374K Buy
19,646
+18
+0.1% +$330 ﹤0.01% 2080
2014
Q3 		$358K Buy
19,628
+612
+3% +$12.4K ﹤0.01% 2080
2014
Q2 		$415K Buy
19,016
+758
+4% +$15.6K ﹤0.01% 2027
2014
Q1 		$372K Buy
18,258
+292
+2% +$6.25K ﹤0.01% 2045
2013
Q4 		$417K Sell
17,966
-2,778
-13% -$58.9K ﹤0.01% 1991
2013
Q3 		$448K Buy
20,744
+3,472
+20% +$76.4K ﹤0.01% 1926
2013
Q2 		$404K Buy
+17,272
New +$449K ﹤0.01% 1950

Other funds holding MDC

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
WIA
Wetzel Investment Advisors Indianapolis, Indiana $252M AUM 18.78% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

T. Rowe Price Associates's MDC Position: Q2 2024 in Review

T. Rowe Price Associates sold out of M.D.C. Holdings, Inc. (MDC) in Q2 2024, closing a stake of 51,013 shares — an estimated $3.21M sold.

T. Rowe Price Associates first reported a position in MDC in Q2 2013 and held it in 44 quarters. The position peaked at $3.21M in Q1 2024. 4 funds tracked by Wall St. Rank hold MDC as of Q2 2024.

  • T. Rowe Price Associates reported no remaining M.D.C. Holdings, Inc. position as of Q2 2024 after selling out during the quarter.
  • T. Rowe Price Associates sold 51,013 M.D.C. Holdings, Inc. shares in Q2 2024, an estimated $3.21M.
  • T. Rowe Price Associates first reported a position in M.D.C. Holdings, Inc. in Q2 2013 and held it in 44 quarters.
  • T. Rowe Price Associates's M.D.C. Holdings, Inc. position peaked at $3.21M in Q1 2024.
  • 4 funds tracked by Wall St. Rank held M.D.C. Holdings, Inc. as of Q2 2024.

Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.